Favourable long-term effects of a cardiovascular prevention program in primary health care in Sweden in men, and women on first cardiovascular events, cardiovascular mortality, and all-cause mortality

被引：0
|
作者：
Journath, G. [1 ]
Hammar, N. [2 ,3 ]
Hammar, N. [2 ,3 ]
Vikstrom, M. [4 ]
Linnersjo, A. [5 ,6 ]
Linnersjo, A. [5 ,6 ]
Walldius, G. [2 ]
Krakau, I. [7 ]
Lindgren, P. [8 ,9 ]
De Faire, U. [4 ]
Hellenius, M. L. [1 ]
机构：
[1] Karolinska Inst, Dept Med, Cardiol Unit, Stockholm, Sweden
[2] Karolinska Inst, Inst Environm Med, Div Epidemiol, Stockholm, Sweden
[3] AstraZeneca R&D, Molndal, Sweden
[4] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, Stockholm, Sweden
[5] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden
[6] Karolinska Inst, Inst Environm Med, Unit Occupat Med, Stockholm, Sweden
[7] Karolinska Inst, Dept Med, Unit Clin Epidemiol, Stockholm, Sweden
[8] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden
[9] Swedish Inst Hlth Econ, Stockholm, Sweden
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4389
引用
收藏
页码：879 / 879
页数：1
相关论文
共 50 条
  • [41] Association of social relationships with incident cardiovascular events and all-cause mortality
    Gronewold, J.
    Kropp, R.
    Lehmann, N.
    Schmidt, B.
    Weyers, S.
    Siegrist, J.
    Dragano, N.
    Joeckels, K. -H
    Erbe, R.
    Hermann, D. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 360 - 360
  • [42] SARCOPENIC OBESITY AND RISK OF ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN OLDER MEN
    Atkins, J. L.
    Whincup, P. H.
    Morris, R. W.
    Wannamethee, S. G.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2012, 66 : A53 - A53
  • [43] Body Adiposity Index and All-Cause and Cardiovascular Disease Mortality in Men
    Moliner-Urdiales, Diego
    Artero, Enrique G.
    Lee, Duck-chul
    Espana-Romero, Vanesa
    Sui, Xuemei
    Blair, Steven N.
    OBESITY, 2013, 21 (09) : 1870 - 1876
  • [44] Parathyroidectomy reduces cardiovascular events and all-cause mortality in renal hyperparathyroidism
    Lima, Jose
    Costa-Hong, Valeria
    Jorgetti, Vanda
    Gowdalk, Luis Henrique W.
    Moyses, Rosa Maria A.
    Krieger, Eduardo M.
    CIRCULATION, 2007, 116 (16) : 191 - 192
  • [45] Heart rate reserve as a predictor of cardiovascular and all-cause mortality in men
    Cheng, YJ
    Macera, CA
    Church, TS
    Blair, SN
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2002, 34 (12): : 1873 - 1878
  • [46] Effects of Running on Chronic Diseases and Cardiovascular and All-Cause Mortality
    Lavie, Carl J.
    Lee, Duck-chul
    Sui, Xuemei
    Arena, Ross
    O'Keefe, James H.
    Church, Timothy S.
    Milani, Richard V.
    Blair, Steven N.
    MAYO CLINIC PROCEEDINGS, 2015, 90 (11) : 1541 - 1552
  • [47] LONG-TERM MORTALITY AFTER PRIMARY PREVENTION FOR CARDIOVASCULAR-DISEASE
    MODEST, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (16): : 2184 - 2184
  • [48] New-onset diabetes and risk of all-cause and cardiovascular mortality - The cardiovascular health study
    Smith, Nicholas L.
    Lumley, Thomas
    Barzilay, Joshua I.
    Enquobahrie, Daniel
    Kronmal, Richard
    Psaty, Bruce M.
    DIABETES CARE, 2006, 29 (09) : 2012 - 2017
  • [49] Cause of Death in Heart Failure Based on Etiology: Long-Term Cohort Study of All-Cause and Cardiovascular Mortality
    Spitaleri, Giosafat
    Zamora, Elisabet
    Cediel, German
    Codina, Pau
    Santiago-Vacas, Evelyn
    Domingo, Mar
    Lupon, Josep
    Santesmases, Javier
    Diez-Quevedo, Crisanto
    Troya, Maria Isabel
    Boldo, Maria
    Altimir, Salvador
    Alonso, Nuria
    Gonzalez, Beatriz
    Bayes-Genis, Antoni
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)
  • [50] Long-term clinical outcomes in steatotic liver disease and incidence of liver-related events, cardiovascular events and all-cause mortality
    Tamaki, Nobuharu
    Kimura, Takefumi
    Wakabayashi, Shun-Ichi
    Umemura, Takeji
    Kurosaki, Masayuki
    Loomba, Rohit
    Izumi, Namiki
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (01) : 61 - 69
12345